Metabolic HealthNCT07765394
A Clinical Trial to Evaluate the Effects of A Supplement on Supporting Signs of Metabolic Health
A study testing Hello Burn Activate in people with Metabolic Health and Weight Management, run by Love Wellness at 1 site in United States.
Trial summary
This study evaluates the effects of the Love Wellness supplement Hello Burn Activate on supporting metabolic health in adult females. The 12-week, single-arm, open-label, virtual trial will enroll 40 female participants aged 25-45 who are experiencing challenges with healthy weight management and body confidence. Read more about this study
- Who is it for?
- Ages 25 to 45 yearsHealthy volunteers can take part
- Conditions the study is for
- Metabolic Health, Weight Management, Body Confidence
- What is being tested?
- Hello Burn Activate
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteUnited States
- Study dates
- 7 Apr 2025to 28 Jul 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 45 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Be female.
- Be aged 25-45.
- Currently experiencing issues regarding healthy weight management.
- Currently experiencing issues regarding body confidence.
- Currently experiencing difficulty maintaining a weight management routine.
- Generally healthy - does not live with any uncontrolled chronic disease.
Show all 9Show fewer
- Willing to refrain from taking any products, prescription medications, or supplements that target metabolic health during the test period.
- Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study.
- Resides in the United States.
Who cannot join
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period.
- Anyone taking a prescription GLP-1 medication, including but not limited to Ozempic, Wegovy, or Mounjaro.
- Anyone taking a prescription anticoagulant ('blood thinner') medication.
- Anyone taking a prescription antibiotic.
- Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men).
- Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
Show all 9Show fewer
- Anyone participating in another research study within the next 12 weeks.
- Anyone unwilling to follow the study protocol.
- Anyone with any allergies or sensitivities to any of the study product ingredients.
Trial locations and contacts
1 site in 1 country.
About this study
This study evaluates the effects of the Love Wellness supplement Hello Burn Activate on supporting metabolic health in adult females. The 12-week, single-arm, open-label, virtual trial will enroll 40 female participants aged 25-45 who are experiencing challenges with healthy weight management and body confidence.
All participants will take one capsule of the test product daily in the morning with their first meal. Participants will complete self-reported questionnaires at Baseline, Week 4, Week 8, and Week 12 to assess changes in perceived metabolic health, body confidence, overall health, and well-being.
- Conditions
- Metabolic Health, Weight Management, Body Confidence, Gut Health
- Being tested
- Hello Burn Activate
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hello Burn ActivateDietary supplement
All enrolled participants take one capsule of Hello Burn Activate (containing heat-treated Bifidobacterium animalis lactis BPL1, inulin, vegetable capsule [hypromellose, water], and medium chain triglycerides) once daily in the morning with the first meal of the day for 12 weeks.
| Study group | Role | What they receive |
|---|---|---|
| Hello Burn Activate | Experimental | Not described Receives: Dietary Supplement: Hello Burn Activate |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Perceived Metabolic Health
Self-reported assessment of overall metabolic health via self-reported questionnaire
Measured: Baseline, Week 4, Week 8, and Week 12
Secondary outcomes (3)
Change in Body Confidence
Self-reported assessment of body confidence via self-reported questionnaire
Measured: Baseline, Week 4, Week 8, and Week 12
Change in Overall Well-Being
Self-reported assessment of overall well-being via self-reported questionnaire
Measured: Baseline, Week 4, Week 8, and Week 12
Change in Overall Health
Self-reported assessment of overall health via self-reported questionnaire
Measured: Baseline, Week 4, Week 8, and Week 12
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Aug 2026
- Study start7 Apr 2025
- Primary completion28 Jul 2025
- Study completion28 Jul 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Metabolic HealthStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- Love Wellness
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07765394
- Sponsor's protocol ID
- 20745
- Other IDs
- legacy-20745
- Status last verified
- Aug 2026
- First submitted
- 11 Aug 2026
- Last updated
- 14 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Clinical Trial to Evaluate the Effects of A Supplement on Supporting Signs of Metabolic Health
- ClinicalTrials.gov ID
- NCT07765394
- Acronym / sponsor ID
- 20745
- Conditions
- Metabolic Health, Weight Management, Body Confidence, Gut Health
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- Love WellnessIndustry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Study start
- 7 Apr 2025 (actual)
- Primary completion
- 28 Jul 2025 (actual)
- Study completion
- 28 Jul 2025 (actual)
- First posted
- 14 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluates the effects of the Love Wellness supplement Hello Burn Activate on supporting metabolic health in adult females. The 12-week, single-arm, open-label, virtual trial will enroll 40 female participants aged 25-45 who are experiencing challenges with healthy weight management and body confidence.
All participants will take one capsule of the test product daily in the morning with their first meal. Participants will complete self-reported questionnaires at Baseline, Week 4, Week 8, and Week 12 to assess changes in perceived metabolic health, body confidence, overall health, and well-being.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Hello Burn Activate | Experimental | Dietary Supplement: Hello Burn Activate |
Who may qualify
- Ages
- 25 to 45 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (9 listed)
- Be female.
- Be aged 25-45.
- Currently experiencing issues regarding healthy weight management.
- Currently experiencing issues regarding body confidence.
- Currently experiencing difficulty maintaining a weight management routine.
Key exclusion criteria (9 listed)
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period.
- Anyone taking a prescription GLP-1 medication, including but not limited to Ozempic, Wegovy, or Mounjaro.
- Anyone taking a prescription anticoagulant ('blood thinner') medication.
- Anyone taking a prescription antibiotic.
- Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hello Burn ActivateAll enrolled participants take one capsule of Hello Burn Activate (containing heat-treated Bifidobacterium animalis lactis BPL1, inulin, vegetable capsule [hypromellose, water], and medium chain triglycerides) once daily in the morning with the first meal of the day for 12 weeks. | Dietary supplement | Hello Burn Activate |
Primary outcome
Change in Perceived Metabolic Health
Time frame: Baseline, Week 4, Week 8, and Week 12
Self-reported assessment of overall metabolic health via self-reported questionnaire
3 secondary outcomes
Change in Body Confidence
Time frame: Baseline, Week 4, Week 8, and Week 12
Change in Overall Well-Being
Time frame: Baseline, Week 4, Week 8, and Week 12
Change in Overall Health
Time frame: Baseline, Week 4, Week 8, and Week 12
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Aug 2026.
Related trials for Metabolic Health
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
SweetSpot - The Effect of Non-nutritive Sweeteners on Health
Healthy Adult
Not yet recruitingPhase 2
Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma
Acute Lymphoblastic Leukemia in Remission, Hodgkin Lymphoma in Remission
Not yet recruitingObservational study
Evaluating Metabolic Health in Individuals With Extreme Obesity
BMI>40
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Hello Burn Activate in people with Metabolic Health and Weight Management, run by Love Wellness at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Perceived Metabolic Health (time frame: Baseline, Week 4, Week 8, and Week 12). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2026.